{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:57:29Z","timestamp":1790150249671,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26460302"],"award-info":[{"award-number":["26460302"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["23390044"],"award-info":[{"award-number":["23390044"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["26670453"],"award-info":[{"award-number":["26670453"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["10036069"],"award-info":[{"award-number":["10036069"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health, Labor, and Welfare","award":["2304-201"],"award-info":[{"award-number":["2304-201"]}]},{"DOI":"10.13039\/501100012627","name":"Japan Diabetes Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012627","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.npep.2017.05.003","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T06:46:37Z","timestamp":1495694797000},"page":"77-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Glucagon-like peptide-1 and insulin synergistically activate vagal afferent neurons"],"prefix":"10.1016","volume":"65","author":[{"given":"Yusaku","family":"Iwasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chayon","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Yada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2017.05.003_bb0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2005.03.011","article-title":"The inhibitory effects of peripheral administration of peptide YY3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway","volume":"1044","author":"Abbott","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2017.05.003_bb0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejphar.2016.03.030","article-title":"Evidence for neural contribution to islet effects of DPP-4 inhibition in mice","volume":"780","author":"Ahlkvist","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2017.05.003_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/S1262-3636(16)30002-7","article-title":"Physiological aspects of the combination of insulin and GLP-1 in the regulation of blood glucose control","volume":"41","author":"Ahren","year":"2015","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.npep.2017.05.003_bb0020","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","article-title":"Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin","volume":"19","author":"Banks","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2017.05.003_bb0025","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/ar.a.20088","article-title":"Anatomy and function of sensory hepatic nerves","volume":"280","author":"Berthoud","year":"2004","journal-title":"Anat. Rec. A Discov. Mol. Cell Evol. Biol."},{"key":"10.1016\/j.npep.2017.05.003_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1566-0702(00)00215-0","article-title":"Functional and chemical anatomy of the afferent vagal system","volume":"85","author":"Berthoud","year":"2000","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.npep.2017.05.003_bb0035","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1172\/JCI78361","article-title":"Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells","volume":"125","author":"Bohorquez","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.npep.2017.05.003_bb0040","doi-asserted-by":"crossref","first-page":"R2163","DOI":"10.1152\/ajpregu.00911.2006","article-title":"Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system","volume":"293","author":"D'Alessio","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.npep.2017.05.003_bb0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.physbeh.2011.12.001","article-title":"Nutrient detection by incretin hormone secreting cells","volume":"106","author":"Diakogiannaki","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.npep.2017.05.003_bb0050","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/S0140-6736(14)61335-0","article-title":"Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis","volume":"384","author":"Eng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.npep.2017.05.003_bb0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1471-4159.2011.07563.x","article-title":"Intraportal administration of DPP-IV inhibitor regulates insulin secretion and food intake mediated by the hepatic vagal afferent nerve in rats","volume":"121","author":"Fujiwara","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2017.05.003_bb0060","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1152\/jn.1978.41.5.1217","article-title":"Membrane and action potential characteristics of A and C nodose ganglion cells studied in whole ganglia and in tissue slices","volume":"41","author":"Gallego","year":"1978","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.npep.2017.05.003_bb0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0969-8051(98)00121-8","article-title":"In vivo dynamic distribution of 131I-glucagon-like peptide-1 (7-36) amide in the rat studied by gamma camera","volume":"26","author":"Hassan","year":"1999","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.npep.2017.05.003_bb0070","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.npep.2017.05.003_bb0075","first-page":"G920","article-title":"Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms","volume":"273","author":"Imeryuz","year":"1997","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.npep.2017.05.003_bb0080","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.npep.2012.08.009","article-title":"Vagal afferents sense meal-associated gastrointestinal and pancreatic hormones: mechanism and physiological role","volume":"46","author":"Iwasaki","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.05.003_bb0085","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.bbrc.2009.10.085","article-title":"Nesfatin-1 evokes Ca2+ signaling in isolated vagal afferent neurons via Ca2+ influx through N-type channels","volume":"390","author":"Iwasaki","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.npep.2017.05.003_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067198","article-title":"Insulin activates vagal afferent neurons including those innervating pancreas via insulin cascade and Ca influx: its dysfunction in IRS2-KO mice with hyperphagic obesity","volume":"8","author":"Iwasaki","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.npep.2017.05.003_bb0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.npep.2015.06.003","article-title":"Ghrelin counteracts insulin-induced activation of vagal afferent neurons via growth hormone secretagogue receptor","volume":"52","author":"Iwasaki","year":"2015","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.05.003_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1566-0702(02)00182-0","article-title":"Glucagon-like peptide-1 evokes action potentials and increases cytosolic Ca2+ in rat nodose ganglion neurons","volume":"102","author":"Kakei","year":"2002","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.npep.2017.05.003_bb0105","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1210\/en.2011-0174","article-title":"Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4","volume":"152","author":"Kanoski","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.npep.2017.05.003_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1385\/JMN:18:1-2:07","article-title":"Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier","volume":"18","author":"Kastin","year":"2002","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.npep.2017.05.003_bb0115","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/jdi.12423","article-title":"Combination therapy of glucagon-like peptide-1 receptor agonists and insulin for patients who developed diabetes after partial pancreatectomy","volume":"7","author":"Kitazawa","year":"2016","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.npep.2017.05.003_bb0120","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2337\/diabetes.52.4.948","article-title":"Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin","volume":"52","author":"Kohno","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.npep.2017.05.003_bb0125","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.physbeh.2015.06.001","article-title":"Vagal mediation of GLP-1's effects on food intake and glycemia","volume":"152","author":"Krieger","year":"2015","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.npep.2017.05.003_bb0130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/db15-0973","article-title":"Knockdown of GLP-1 receptors in vagal afferents affects normal food intake and glycemia","volume":"65","author":"Krieger","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.npep.2017.05.003_bb0135","doi-asserted-by":"crossref","first-page":"E320","DOI":"10.1152\/ajpendo.00446.2014","article-title":"Arcuate Na+, K+-ATPase senses systemic energy states and regulates feeding behavior through glucose-inhibited neurons","volume":"309","author":"Kurita","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.npep.2017.05.003_bb0140","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1475-2840-11-142","article-title":"Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity","volume":"11","author":"Li","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.npep.2017.05.003_bb0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.autneu.2003.11.001","article-title":"Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells","volume":"110","author":"Nakagawa","year":"2004","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.npep.2017.05.003_bb0150","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrendo.2011.30","article-title":"Pharmacotherapy: GLP-1 analogues and insulin: sound the wedding bells?","volume":"7","author":"Nauck","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.npep.2017.05.003_bb0155","doi-asserted-by":"crossref","first-page":"E376","DOI":"10.1152\/ajpendo.00565.2012","article-title":"Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways","volume":"305","author":"Nishizawa","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.npep.2017.05.003_bb0160","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.tem.2004.07.009","article-title":"Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis","volume":"15","author":"Niswender","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.npep.2017.05.003_bb0165","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/db13-1440","article-title":"Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model","volume":"63","author":"Richards","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.npep.2017.05.003_bb0170","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.npep.2017.05.003_bb0175","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","author":"Secher","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.npep.2017.05.003_bb0180","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/jdi.12457","article-title":"Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: a 36-week, randomized, double-blind, parallel-group trial","volume":"7","author":"Seino","year":"2016","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.npep.2017.05.003_bb0185","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1172\/JCI72434","article-title":"Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect","volume":"124","author":"Sisley","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.npep.2017.05.003_bb0190","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.7268408","article-title":"Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat","volume":"213","author":"Smith","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.npep.2017.05.003_bb0195","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.cmet.2014.04.005","article-title":"The role of beta cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs","volume":"19","author":"Smith","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.npep.2017.05.003_bb0200","first-page":"R978","article-title":"Hepatic portal insulin antibody infusion increases, but insulin does not alter, spontaneous meal size in rats","volume":"269","author":"Surina-Baumgartner","year":"1995","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.npep.2017.05.003_bb0205","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1210\/en.2005-0473","article-title":"Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice","volume":"146","author":"Talsania","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.npep.2017.05.003_bb0210","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/1753-0407.12439","article-title":"The incretin hormone GLP-1 and mechanisms underlying its secretion","volume":"8","author":"Tian","year":"2016","journal-title":"J. Diabetes"},{"key":"10.1016\/j.npep.2017.05.003_bb0215","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0031-9384(94)90310-7","article-title":"Insulin is a prandial satiety hormone","volume":"56","author":"VanderWeele","year":"1994","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.npep.2017.05.003_bb0220","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1210\/en.2008-1045","article-title":"Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety","volume":"150","author":"Williams","year":"2009","journal-title":"Endocrinology"}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417917301105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417917301105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T22:44:26Z","timestamp":1656197066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417917301105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":44,"alternative-id":["S0143417917301105"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2017.05.003","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide-1 and insulin synergistically activate vagal afferent neurons","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2017.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}